Lv11
90 积分 2025-06-18 加入
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update
3天前
已完结
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
3天前
已完结
Clinical characteristics and 1‐year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association Database‐Heart Failure Center Registry
4天前
已完结
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
9天前
已完结
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices
9天前
已完结
The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis
10天前
已完结
Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction
10天前
已完结
Effectiveness and Safety of Sacubitril/Valsartan in Heart Failure with Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
10天前
已完结
In‐Hospital or Out‐of‐Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE‐HF Trial
10天前
已关闭
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
10天前
已完结
皖公网安备34019202002308
